2016 Global Life Sciences Outlook
Moving forward with cautious optimism
Die Gesundheitswirtschaft geht mit vorsichtigem Optimismus ins neue Jahr, wie der „2016 Global Life Sciences Outlook“ von Deloitte zeigt. Multinationale Unternehmen aus den Bereichen Pharma, Biotechnologie und Medizintechnik erwarten eine steigende Nachfrage, aber auch Herausforderungen.
Identification of Medicinal Products
Identification of Medicinal Products (IDMP) is one the biggest regulatory challenges for all pharmaceutical companies operating in Europe. How can your organisation navigate this journey towards increased patient safety and use it as an opportunity for business transformation?
The Consumer Goods Forum
Health & Wellness Progress Report 2016
This report provides up-to-date information to help us understand the progress we are making toward positively affecting consumer health and wellness on a global scale. As the survey results show, progress has been made in a number of areas over the last year.
2016 Global health care outlook
Battling costs while improving care
Change is the new normal for the global health care sector. As providers, governments, and other stakeholders strive to deliver effective, efficient, and equitable care, they do so in an ecosystem that is undergoing a dramatic and fundamental shift in business, clinical, and operating models.